Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr;10(2):113-116.
doi: 10.14791/btrt.2022.0004.

Peripheral T-Cell Lymphoma Presenting as a Scalp Mass

Affiliations
Case Reports

Peripheral T-Cell Lymphoma Presenting as a Scalp Mass

Moo Seong Kim et al. Brain Tumor Res Treat. 2022 Apr.

Abstract

Peripheral scalp T-cell lymphoma is a very rare disease. We report a case of a 22-year-old man who presented an indolent large scalp mass in the right frontal scalp region. The patient's physical examination demonstrated no palpable mass in the chest, abdomen, and extremities. The brain CT revealed a high-density large scalp mass of the subgaleal layer in the right frontal and a small scalp mass of the subgaleal layer in the left frontal. The brain MRI showed multifocal enhancing masses in the bilateral dura, the subgaleal layer of the scalp, and the skull. The patient underwent removal of the tumor found in the right frontal scalp. The histologic diagnosis was peripheral T-cell lymphoma. Bone marrow aspiration showed the involvement of T-cell lymphoma. The patient received chemotherapy with cyclophosphamide, vincristine, doxorubicin, and prednisolone (CHOP protocol) for 3 cycles. The patient was discharged without neurological deficit. The patient showed no evidence of recurrence 15 months after surgery. We report a rare case of peripheral T-cell lymphoma mimicking benign scalp tumors.

Keywords: Lymphoma; Mass; Scalp.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. CT shows enlarged frontal large scalp mass. A: Axial view non-contrast. B: Coronal view non-contrast.
Fig. 2
Fig. 2. MRI demonstrating multifocal homogeneously enhancing lesions in the bilateral dura (A) and multiple T2-hyperintense and homogeneously enhancing mass-like lesions involving subgaleal layer of the scalp, left forehead, and left superior orbit, multiple ill-defined enhancing lesions in the skull (B).
Fig. 3
Fig. 3. PET-CT shows mildly hypermetabolic lesions in the lymph nodes in the neck (A) and a diffuse increase of FDG uptake in the bone marrow through the entire body, the right parotid gland, and the anterior mediastinum, the frontal scalp (B).
Fig. 4
Fig. 4. Histopatholgy shows peripheral T-cell lymphoma. A: Diffuse infiltrates of medium-sized lymphoid cells with irregular nuclei (H&E, ×400). Tumor cells were positive for CD3 (B, ×400), negative for CD20 (C, ×400), and positive for CD8 (D, ×400). All follicular helper T cell markers (CD10, BCL6, PD-1) were not expressed.

Similar articles

Cited by

References

    1. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483–492. - PMC - PubMed
    1. Duyndam DA, Biesma DH, van Heesewijk JP. Primary non-Hodgkin’s lymphoma of the cranial vault; MRI features before and after treatment. Clin Radiol. 2002;57:948–950. - PubMed
    1. Batchelor TT. In: Youmans and Winn neurological surgery. 7th ed. Richard Winn H, editor. Philadelphia: Elsevier; 2017. Primary central nervous sysytem lymphomas; pp. 1085–1090.
    1. Ikumi N, Fujita H, Terui T, Takahashi H, Miura K, Hatta Y, et al. Aggressive CD4–CD8–CD45RA+CCR10– primary cutaneous peripheral T-cell lymphoma, not otherwise specified: a case report. Acta Derm Venereol. 2019;99:1176–1177. - PubMed
    1. Lim T, Kim SJ, Kim K, Lee JI, Lim DH, Lee DJ, et al. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. Ann Hematol. 2011;90:1391–1398. - PMC - PubMed

Publication types

Grants and funding